Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3751]

ASH 2025: New combination approach aims to make CAR T more durable in lymphoma

ASH 2025: New combination approach aims to make CAR T more durable in lymphoma

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers 

ASH 2025: ‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukaemia

ASH 2025: ‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukaemia

ASH 2025: Home-based monitoring could transform care for patients receiving T-cell redirecting therapies

ASH 2025: Home-based monitoring could transform care for patients receiving T-cell redirecting therapies

ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL

ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL

A routine blood test could help predict who benefits most from CAR T-cell therapy

A routine blood test could help predict who benefits most from CAR T-cell therapy

ASH 2025: Milder chemo works for rare, aggressive lymphoma

ASH 2025: Milder chemo works for rare, aggressive lymphoma

ASH 2025: Results show long-lasting benefits of CAR T cell therapy for hard-to-treat lymphoma

ASH 2025: Results show long-lasting benefits of CAR T cell therapy for hard-to-treat lymphoma

ASH 2025: Delayed toxicities after CAR T cell therapy for multiple myeloma are connected and potentially preventable

ASH 2025: Delayed toxicities after CAR T cell therapy for multiple myeloma are connected and potentially...

ASH 2025: Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

ASH 2025: Protective regimen allows successful stem cell transplant even without close genetic match between donor...

More from ecancer